Novonesis A/S Class B · OMXCOP:NSIS_B

Novonesis A/S Class B — 9M 2026 Earnings Presentation

11 slides from Novonesis A/S Class B's earnings presentation, Nov 5, 2026

  1. Slide 1: 9M 2026 Conference call

    9M 2026 Conference call November 5, 2026

  2. Slide 2: Forward-looking statement

    Forward-looking statement Disclaimer This presentation includes forward-looking statements, including statements relating to the operating, financial and sustainability performance and results of the group and/or the industry in which it operates. Forward-looking statements include, without limitati

  3. Slide 3: Group

    Food & Health Group Biosolutions 45% 7% 37.9% 55% Organic sales growth Adj. EBITDA margin Planetary Health Group sales and organic sales growth y/y Biosolutions • Organic sales growth of 7% (Q3: 6%) • Volumes ~6% (Q3: ~5%) including ~1pp (Q3: ~1pp) from EURm 7% synergies OSG • Pricing close to 2% (Q

  4. Slide 4: Food & Health Biosolutions

    Food & Health Human Health 24% Biosolutions 76% 9M 2026 • 9% organic sales growth (including ~2pp negative effect from Food & Beverages exiting certain countries) Divisional sales and organic sales growth y/y • Growth mainly driven by volumes incl. synergies, supported by EURm pricing 9% OSG • Adj.

  5. Slide 5: Food & Beverages and Human Health

    Food & Beverages Human Health 9M 2026 9M 2026 • 12% organic sales growth • Flat organic sales performance (including ~3pp negative effect from exiting certain countries) (including ~1pp negative effect from exiting certain countries) • Growth across all industries • Advanced Health & Nutrition perfo

  6. Slide 6: Planetary Health Biosolutions

    Planetary Health Household Care 34% Biosolutions 66% 9M 2026 • 6% organic sales growth Agriculture, Energy & Tech • Growth mainly driven by volume, supported by pricing Divisional sales and organic sales growth y/y • Adj. EBITDA margin at 38.6% EURm 6% OSG Q3 2026 • 4% organic sales growth 4% OSG 1,

  7. Slide 7: Household Care and Agriculture, Energy & Tech

    Household Care Agriculture, Energy & Tech 9M 2026 9M 2026 • 7% organic sales growth • 5% organic sales growth • Strong growth driven by innovation and increased penetration • Growth led by strong growth in Energy supported by across markets Agriculture • Positive impact from pricing • Positive impac

  8. Slide 8: Financial results 9M 2026

    Financial results 9M 2026 • 7% broad-based organic sales growth (Q3: 6%) • 59.8% adj. gross margin (Q3: 60.0%) • 37.9% adj. EBITDA margin (Q3: 38.3%) • 17% free cash flow before acquisitions relative to sales 9M 2025 9M 2026 Q3 2025 Q3 2026 Organic sales growth % 8 7 6 6 Adj. Gross margin % 58.9 59.

  9. Slide 9: Outlook 2026

    Outlook 2026 • Organic sales growth at 7-8% (8-9% excl. exit from certain countries) FY 2026 growth components include: • A good 1 pp from synergies • Around 1.5 pp from pricing • Close to 1 pp negative effect from exiting certain countries • Q4 organic sales growth indicated at high-single-digit •

  10. Slide 10: Q&A

    Q&A

  11. Slide 11: Organic sales performance by region

    Organic sales performance by region Developed markets 9M/Q3 2026: 7%/6% North America Europe, the Middle East & Africa* 9M/Q3 2026: +8%/+10% 9M/Q3 2026: +4%/+4% 62% 31% Asia Pacific of sales of sales 35% of sales 9M/Q3 2026: +8%/+6% Emerging markets* 9M/Q3 2026: 6%/5% Latin America 19% of sales 9M/Q

Novonesis — 9M 2026 Earnings Presentation on 6ix